264 related articles for article (PubMed ID: 30559133)
1. Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
Asua V; Vinden J; Conrad MD; Legac J; Kigozi SP; Kamya MR; Dorsey G; Nsobya SL; Rosenthal PJ
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559133
[TBL] [Abstract][Full Text] [Related]
2. Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.
Tumwebaze P; Tukwasibwe S; Taylor A; Conrad M; Ruhamyankaka E; Asua V; Walakira A; Nankabirwa J; Yeka A; Staedke SG; Greenhouse B; Nsobya SL; Kamya MR; Dorsey G; Rosenthal PJ
J Infect Dis; 2017 Feb; 215(4):631-635. PubMed ID: 28039354
[TBL] [Abstract][Full Text] [Related]
3. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
4. Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda.
Asua V; Conrad MD; Aydemir O; Duvalsaint M; Legac J; Duarte E; Tumwebaze P; Chin DM; Cooper RA; Yeka A; Kamya MR; Dorsey G; Nsobya SL; Bailey J; Rosenthal PJ
J Infect Dis; 2021 Mar; 223(6):985-994. PubMed ID: 33146722
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
Mbogo GW; Nankoberanyi S; Tukwasibwe S; Baliraine FN; Nsobya SL; Conrad MD; Arinaitwe E; Kamya M; Tappero J; Staedke SG; Dorsey G; Greenhouse B; Rosenthal PJ
Am J Trop Med Hyg; 2014 Jul; 91(1):54-61. PubMed ID: 24799371
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
7. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
Tumwebaze P; Conrad MD; Walakira A; LeClair N; Byaruhanga O; Nakazibwe C; Kozak B; Bloome J; Okiring J; Kakuru A; Bigira V; Kapisi J; Legac J; Gut J; Cooper RA; Kamya MR; Havlir DV; Dorsey G; Greenhouse B; Nsobya SL; Rosenthal PJ
Antimicrob Agents Chemother; 2015; 59(6):3018-30. PubMed ID: 25753626
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
[TBL] [Abstract][Full Text] [Related]
9. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
10. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
13.
Zhao W; Li X; Yang Q; Zhou L; Duan M; Pan M; Qin Y; Li X; Wang X; Zeng W; Zhao H; Sun K; Zhu W; Afrane Y; Amoah LE; Abuaku B; Duah-Quashie NO; Huang Y; Cui L; Yang Z
Front Cell Infect Microbiol; 2022; 12():1015957. PubMed ID: 36310880
[TBL] [Abstract][Full Text] [Related]
14. Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province, China.
Zhou R; Yang C; Li S; Zhao Y; Liu Y; Qian D; Wang H; Lu D; Zhang H; Huang F
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358591
[TBL] [Abstract][Full Text] [Related]
15. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia.
Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S
Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Umesumbu SE; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2021 Mar; 20(1):144. PubMed ID: 33706773
[TBL] [Abstract][Full Text] [Related]
17. Correlation of
Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
[TBL] [Abstract][Full Text] [Related]
19. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
[TBL] [Abstract][Full Text] [Related]
20. Selection of
Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
